Article Per Year (5 Year)
p-Index From 2019 - 2024
0.882
P-Index
This Author published in this journals
All Journal Farmaka Indonesian Journal of Pharmaceutical Science and Technology Jurnal Farmasi Klinik Indonesia Pharmacology and Clinical Pharmacy Research
AJENG DIANTINI
Unknown Affiliation
Biochemistry, Genetics & Molecular Biology Chemistry Computer Science & IT Health Professions Immunology & microbiology Materials Science & Nanotechnology Medicine & Pharmacology Public Health

Published : 8 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 8 Documents
Search

 1 
PERAN NUTRASETIKAL PADA KANKER PARU-PARU ALIA RESTI AZURA; AJENG DIANTINI
Farmaka Vol 17, No 2 (2019): Farmaka (Agustus)
Publisher : Fakultas Farmasi, Universitas Padjadjaran

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (136.357 KB) | DOI: 10.24198/jf.v17i2.22044

Abstract

ABSTRAKKanker paru-paru terjadi saat sel abnormal tumbuh pada jaringan paru-paru. Kanker paru-paru menjadi penyakit yang paling umum dalam menyebabkan kematian. Salah satu pencegahan yang dapat dilakukan pada kanker paru-paru adalah menggunakan nurtrasetikal. Nutrasetikal merupakan suatu nutrisi yang dapat digunakan untuk membantu menjaga kesehatan dan mencegah timbulnya suatu penyakit. Tujuan dilakukan review artikel ini yaitu untuk mengetahui nutrasetikal apa saja yang dapat digunakan pada kanker paru-paru. Hasil yang didapatkan adalah cruciferous vegetable, bawang putih, kacang, kedelai, vitamin D dan minyak ikan memiliki kemampuan untuk menurunkan risiko kanker paru-paru dan meningkatkan kualitas hidup. Dapat disimpulkan terdapat berbagai macam nutrasetikal yang memberikan manfaat pada kanker paru-paruKata kunci: Kanker paru-paru, nutrasetikal, pencegahanABSTRACTLung cancer occurs when abnormal cell growth in lung tissue. Lung cancer becomes the most common disease in causing death. One prevention that can be done for lung cancer is using nutraceutical. Nutraceutical is a nutrient that can be used to help maintain health and prevent the onset of an illness. The purpose of this article review is to know what nutraceutical can be used in lung cancer.  The results were obtained that cruciferous vegetable, garlic, nut, soy, vitamin D dan fish oil have the ability to lower the risk of lung cancer and improve the quality of life. It can be concluded that there are various kinds of nutraceutical that gives benefit for lung cancer.Keyword: Lung cancer, nutraceutical, prevention
Antiproliferation Assay of Essential Oil of Curcuma Rhizoma (Curcuma xanthorrhiza Roxb.) Against P388 Leukemia Cell Ida Musfiroh; Angga Geganaputra; Ajeng Diantini; Yasmiwar Susilawati; Muchtaridi Muchtaridi
Indonesian Journal of Pharmaceutical Science and Technology Vol 7, No 3 (2020)
Publisher : Indonesian Journal of Pharmaceutical Science and Technology

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.24198/ijpst.v7i3.27210

Abstract

Leukemia or blood cancer is a disease which marked by abnormal increasing of blood producer`s cells. Chemotherapies which used as anticancer have a many adverse effect and toxicity. The volatile oil of turmeric rhizome (Curcuma xanthorriza) contains sesquiterpene which has an pharmacological activity. The aimed of this research to assay the antiproliferation activity of volatile oil from curcuma rhizome to leukemia P388 cells using MTT (3-[4,5-dimethylthiazole-2-yl]-2,5-diphenyl tetrazolium bromide) method. The methods were contain of identification of volatile oil (produced from distillation water-steam) using organoleptic test and TLC, and activity test was using seven various concentrations, which were 0.1; 0.3; 1; 3; 10; 30; 100 µg/mL. The result showed that the sample can inhibit leukemia P388 cells with the value of IC50 was 15.5 µg/mL. The volatile oil of Curcuma rhizome has an antiproliferative activity to leukemia P388 cell.Keywords: Curcuma rhizome, MTT assay, leukemia cell P388, volatile oil
Stabilitas Sampel SOD-Eritrosit dan GPx-Blood dalam Masa Penyimpanan Tujuh Hari Miswar Fattah; Sra R. Anggraeni; Sofa D. Alfian; Jutti Levita; Ajeng Diantini
Indonesian Journal of Clinical Pharmacy Vol 1, No 4 (2012)
Publisher : Universitas Padjadjaran

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (632.948 KB)

Abstract

Telah dilakukan penelitian mengenai aktivitas SOD eritrosit pada hari ke-0, 1, 3, 5, 7 dengan sentrifugasipada suhu ruangan (22,5 0C) dan pada suhu penyimpanan -80 0C, aktivitas SOD pada hari ke-0 dengan sentrifugasi pada suhu 4 0C, dan aktivitas SOD dengan inkubasi sampel whole blood selama satu hari pada suhu 2–8 0C serta aktivitas GPx hari ke-0, 1, 3, 5, 7 pada suhu penyimpanan 2–8 0C. Penelitian ini menggunakan reagen dari Randox Laboratories yang diukur pada panjang gelombang 505 nm untuk SOD dan 340 nm untuk GPx menggunakan alat Hitachi 917 dari Boehringer Mannheim. Data yang dianalisis menggunakan metode t-test menunjukkan bahwa aktivitas SOD pada hari ke-0, 1, 3, 5, dan 7 dengan sentrifugasi pada suhu ruangan tidak menunjukkan perbedaan yang signifikan, sedangkan pada hari ke-0 dengan sentrifugasi pada suhu 4 0C dan inkubasi sampel whole blood selama 1 hari pada suhu 2–8 0C berbeda secara signifikan. Aktivitas GPx pada hari ke-3 tidak berbeda secara signifikan, sementara aktivitas pada hari ke-0, 1, 5 dan 7 terdapat perbedaan yang signifikan.Kata kunci: Stabilitas enzim, Superoxide Dismutase (SOD), Glutathione Peroxidase (GPx) Stability of Seven Days Sample Storage of Erythrocyte’s SOD and Blood’s GPxAbstractThe research was about SOD erythrocyte activities at day 0, 1, 3, 5, and 7 which centrifuged at room temperature (22.5 0C) and storage temperature (-80 0C), SOD activities at day-0 which centrifuged at 4 0C, SOD whole blood activities with one day incubated at 2-8 0C and GPx activities at day 0, 1, 3, 5, and 7 with 2–8 0C storage temperature. Laboratory analysis were performed by using reagent from Randox Laboratories, and Hitachi 917 analyzer from Boehringer Mannheim. SOD activities were measured at 505 nm absorbance meanwhile 340 nm absorbance is used to measure GPx. Data was analyzed by using t-test method and showed that SOD activities at day 0, 1, 3, 5, and 7 with room temperature centrifuged had no significant differences. Significant differences are found at day-0 with centrifuged at 4 0C and one day incubated whole blood at 2–8 0C. GPx activities at day- 3 had no significant differences. Significant differences are found at day-0,1, 5 and 7 after storage.Key words: Enzyme stability, Superoxide Dismutase (SOD), Glutathione Peroxidase (GPx)
Efficacy and Side Effects of Deferasirox and Deferiprone for Thalasemia Major in Children Asti Y. Rindarwati; Ajeng Diantini; Keri Lestari
Pharmacology and Clinical Pharmacy Research Vol 1, No 3
Publisher : Universitas Padjadjaran, Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (313.813 KB) | DOI: 10.15416/pcpr.v1i3.15218

Abstract

Thalassemia major (TM) is an inherited disease caused by defective or absent of hemoglobin chain synthesis. Regular chelation therapy is necessary to reduce excess iron in several organs of TM patients. The most commonly used chelating agents are deferasirox and deferiprone. However, information regarding their effectiveness and side effects in Indonesian children population with TM were limited. This study was conducted to assess the effectiveness and side effects of deferasirox and deferiprone in pediatric patients with TM. This was an observational study with prospective analysis which was conducted during April-August 2015. We included pediatric patients with TM who visited a hospital in Bandung, Indonesia, using consecutive sampling method. Thirty two subjects were divided into two groups, i.e., deferasirox and deferiprone group. Review of medical records and interview were performed for each participants. Effectiveness was defined as reduction in ferritin level. Side effects were assessed using Naranjo scale. Data were analyzed using Mann-Whitney test, Wiloxon test and Chi square test. P value < 0.05 defined statistical significance. We found that deferasirox was more effective than deferiprone for the treatment of TM in pediatric patiens, with less side effects. The use of deferasirox as iron chelating agent is recommended for patients with TM.Keywords: deferasirox, deferiprone, ferritin, thalassemia major
Effectiveness of Erythropoietin in Hypertensive Hemodialysis Patients Susannia Ibrahim; Ajeng Diantini; Budhi Prihartanto; Rudi Supriyadi
Pharmacology and Clinical Pharmacy Research Vol 2, No 2
Publisher : Universitas Padjadjaran, Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (273.204 KB) | DOI: 10.15416/pcpr.v2i2.15245

Abstract

Chronic renal failure (CRF) is one the most prevalent health problems among the elderly. Onthe fifth stage of CRF, the patient becomes eligible to hemodialysis. CRF-induced anemiais commonly treated with Erythropoietin (Epo). Information regarding the effectiveness ofEpo in hypertensive hemodialysis patients was limited. Therefore, this study was conductedto evaluate the effectiveness of Epo in hypertensive hemodialysis patients. This study usedan observational case-control analytic method. Data were retrieved from the medical recordsof hemodialysis patients during March-May 2014. A total of 54 participants were included.The increase of haemoglobin (Hb) in controlled hypertension was 0.6257 g/dl, while the inuncontrolled hypertension group, there was a decrease in Hb (-0.1590 g/dl). The use of Epowas more effective in hemodialysis patients with controlled hypertension.Keywords: chronic kidney disease, erythropoietin, hypertension
CATECHOL-O-METHYLTRANSFERASE VAL158MET GENE POLYMORPHISM IN SCHIZOPHRENIA RISPERIDONE-TREATED PATIENTS Fitri N. Ramadhani; Ajeng Diantini; Shelly Iskandar; Melisa I. Barliana
Farmaka Vol 18, No 4 (2020): Farmaka (Suplemen)
Publisher : Fakultas Farmasi, Universitas Padjadjaran

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.24198/farmaka.v18i4.42482

Abstract

Catechol-O-Methyltransferase (COMT) gene is located at chromosome 22q11 on a location with a high risk of the occurrence of schizophrenia that has a role in the degradation and inactivation of dopamine neurotransmitters. The COMT Val158Met gene polymorphism has enzymatic activity variation that can affect the availability of COMT enzyme, balance of dopamine level, and availability of dopamine receptors so it can influence the effectiveness of risperidone therapy that varies. The aim of this study was to observe the genetic profile of COMT Val158Met gene polymorphism and its correlation with effectiveness of risperidone therapy either single or combination in schizophrenia patients at Mental Hospital of Prof. Dr. Soerojo Magelang. This study was an observational descriptive study with a cross-sectional plan. Data collection was carried out prospectively through assessment of risperidone therapy effectiveness based on PANSS-EC scores in medical record, whole blood sampling, and identification of COMT Val158Met gene polymorphism using Polymerase Chain Reaction-Amplification Refractory Mutation System (PCR-ARMS) method. The result of study showed that all schizophrenia patients at Mental Hospital of Prof. Dr. Soerojo Magelang had heterozygote Val/Met (GA) genotype. Combination risperidone therapy was the most widely used (90.79%) rather than single with the result that 44 patients of 69 patients (63.77%) responded to the combination risperidone. Combined risperidone clozapine therapy was the most widely used (57.97%) with the result that 23 patients out of 40 (57.50%) responded to the combination therapy.
KORELASI POLIMORFISME GEN ERCC1 RS11615 DENGAN EFEKTIVITAS KEMOTERAPI BERBASIS-PLATINUM PADA PASIEN KANKER PARU JENIS KARSINOMA BUKAN SEL KECIL Muhammad F. Effendi; Nadiya N. Afifah; Ajeng Diantini; Ruri Intania; Melisa I. Barliana
Farmaka Vol 18, No 4 (2020): Farmaka (Suplemen)
Publisher : Fakultas Farmasi, Universitas Padjadjaran

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.24198/farmaka.v18i4.42350

Abstract

Kemoterapi berbasis platinum merupakan regimen kemoterapi lini pertama untuk pasien kanker paru jenis karsinoma bukan sel kecil (KPKBSK) pada stadium lanjut dan non-operasi tanpa mutasi gen Epidermal growth factor receptor (EGFR). Excision repair cross-complementation group 1 (ERCC1) adalah enzim yang mengeksekusi insisi dari untai DNA yang rusak dan menghilangkan aduksi DNA yang diinduksi oleh platinum. Tujuan penelitian ini adalah untuk mengetahui korelasi polimorfisme gen ERCC1 rs11615 dengan efektivitas kemoterapi berbasis-platinum pada pasien KPKBSK di RS Paru dr. H. A. Rotinsulu Bandung pada bulan November 2019 sampai dengan Maret 2020. Penelitian ini merupakan observasional analitik dengan desain penelitian kohort prospektif terhadap 28 pasien. Polimorfisme gen ERCC1 rs11615 diidentifikasi dengan metode DNA squencing, sedangkan untuk efektivitas kemoterapi menggunakan metode response evaluation criteria in solid tumour (RECIST) dan analisis Cytokeratin 19 fragments (CYFRA 21-1). Hasil penelitian menunjukkan adanya frekuensi alel gen ERCC1 rs11615 masing-masing 50% (C/C), 35,7% (C/T), dan 14,3% (T/T). Tidak terdapat hubungan yang signifikan antara polimorfisme gen ERCC1 rs11615 dengan nilai RECIST (OR = 0,417; 95% confidence interval (CI): 0,091-1,908, P=0,256) atau dengan nilai CYFRA 21-1 (OR = 0,417; 95% confidence interval (CI): 0,063-2,768, P=0,357). Kami tidak menemukan bukti yang mendukung penggunaan gen ERCC1 rs11615 sebagai prediktor untuk menentukan efektivitas kemoterapi berbasis platinum. Dibutuhkan sampel yang memadai untuk mengkonfirmasi secara statistik korelasi polimorfisme gen ERCC1 rs11615 terhadap efektivitas kemoterapi.
HIPOKSIA VERSUS NORMOKSIA: UJI PRELIMINARI KONDISI LINGKUNGAN IN VITRO YANG BAIK UNTUK PRODUKSI MEDIUM TERKONDISI SEL PUNCA MESENKIMAL Yanni Dirgantara; Ajeng Diantini; Cynthia R. Sartika
Farmaka Vol 18, No 4 (2020): Farmaka (Suplemen)
Publisher : Fakultas Farmasi, Universitas Padjadjaran

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.24198/farmaka.v18i4.42347

Abstract

Sel punca mesenkimal (SPM) telah banyak digunakan dalam uji klinis maupun pre klinis dan menunjukkan hasil yang cukup menjanjikan sebagai alternatif terapi pengobatan penyakit degeneratif. Efektivitas terapi SPM bukan hanya dipengaruhi oleh sel yang ditransplantasikan, tetapi juga oleh efek parakrin SPM melalui sekresi molekul sinyaling berupa protein baik secara in vivo maupun in vitro. Efek parakrin terjadi saat sel menerima signal kerusakan, yang secara in vitro dapat dikondisikan dengan pengaturan lingkungan hipoksia bagi pertumbuhan sel. Penelitian ini membandingkan total protein yang dihasilkan oleh SPM dari dua macam sumber, yaitu jaringan tali pusat dan lemak, yang dikultur dalam kondisi hipoksia dan normoksia selama 24 dan 48 jam. Hasil penelitian menunjukkan bahwa protein yang dihasilkan oleh SPM dari jaringan lemak menghasilkan protein dalam jumlah yang lebih banyak dibandingkan dengan SPM dari tali pusat. Sedangkan jika dilihat dari parameter waktu perlakuan, protein yang dihasilkan setelah perlakuan 48 jam lebih banyak dibandingkan protein yang dihasilkan oleh perlakuan selama 24 jam.
Co-Authors ALIA RESTI AZURA Angga Geganaputra Asti Y. Rindarwati Budhi Prihartanto Cynthia R. Sartika Fitri N. Ramadhani Ida Musfiroh Jutti Levita Keri Lestari Melisa I. Barliana Miswar Fattah Muchtaridi Muchtaridi Muhammad F. Effendi Nadiya N. Afifah Rudi Supriyadi Ruri Intania Shelly Iskandar Sofa D. Alfian Sra R. Anggraeni Susannia Ibrahim Yanni Dirgantara Yasmiwar Susilawati